SCBIO focuses on advancing biomanufacturing technologies that enhance the production of biologics and other therapeutic products. Their innovative approaches leverage cutting-edge techniques in cell culture, purification, and formulation to optimize yield and efficiency. By employing advanced analytics and automation, SCBIO aims to streamline the biomanufacturing process, reducing time and costs while maintaining high-quality standards for the final products.

In addition to biomanufacturing, SCBIO emphasizes the importance of scientific research and development in driving innovation. The company collaborates with academic institutions and industry partners to explore novel applications of biotechnology, including gene therapy and regenerative medicine. Their commitment to scientific excellence is reflected in their rigorous testing and validation processes, ensuring that their technologies not only meet regulatory requirements but also address the evolving needs of the healthcare sector.

South Korea

SCBIO is a pharmaceutical company focusing on making drugs to improve wellbeing by allowing accessible medicines to all patients in needs with highly specialized technologies in immuno-oncology. The vision of the company lay in utilizing cutting edge technologies. With sophisticated and precise technologies, we discover and develop novel therapeutics leading innovations for future medicine. Utilizing our technological capabilities enables SCBIO team the ability, to apply cutting edge technologies, to offer smart and timely solutions for product selection, launch strategies and supply mitigating.​

SCBIO

Company Details